The presence of cardiac metastasis has not been extensively evaluated in these patients presenting with increased BNP levels; BNP has been found to be a sensitive marker denoting cardiac metastasis in patients with non-small-cell lung cancer (N-SCLC) [7]. The gene discussed is NPPB; the disease is non-small cell lung carcinoma.